LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition. 2023

Yating Zhan, and Qiqi Tao, and Qishan Meng, and Rongrong Zhang, and Lifan Lin, and Xinmiao Li, and Lei Zheng, and Jianjian Zheng
Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.

Long non-coding RNA-myocardial infarction-associated transcript (lncRNA-MIAT) has been reported to play an important role in the development of multiple cancers. However, the biological roles of MIAT in liver fibrosis are still unknown. In this study, the expression of MIAT is up-regulated during liver fibrosis. Silencing MIAT leads to the suppression of hepatic stellate cell (HSC) proliferation and collagen expression. Double immunofluorescence analysis additionally demonstrates that MIAT inhibition leads to the suppression of type I collagen and α-SMA in vitro. In vivo, MIAT knockdown contributes to the inhibition of fibrosis progression and collagen accumulation. MIAT is confirmed as a target of miR-3085-5p, and the co-location of MIAT and miR-3085-5p is found in HSC cytoplasm. Interestingly, there is a negative correlation between MIAT expression and miR-3085-5p level in cirrhotic patients as well as activated HSCs. In addition, the effects of MIAT inhibition on HSC inactivation are blocked down by miR-3085-5p inhibitor. YAP is a target of miR-3085-5p. Reduced YAP caused by loss of MIAT is reversed by miR-3085-5p inhibitor. Notably, YAP knockdown results in the suppression of MIAT-mediated epithelial-to-mesenchymal transition (EMT) process. In conclusion, we demonstrate that MIAT enhances the activation of HSCs, at least in part, via miR-3085-5p/YAP/EMT signaling pathway.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090683 Hippo Signaling Pathway A signaling pathway that plays a key role in regulating tissue and organ growth. The name derives from the protein kinase Hippo (Hpo) found in DROSOPHILA; where mutations of the Hpo gene result in tissue overgrowth and the hippopotamus phenotype. Hippo Pathway,Hippo Signaling,Hippo Signaling Pathways,Signaling Pathway, Hippo
D055166 Hepatic Stellate Cells Perisinusoidal cells of the liver, located in the space of Disse between HEPATOCYTES and sinusoidal endothelial cells. Ito Cells,Cell, Hepatic Stellate,Cells, Hepatic Stellate,Cells, Ito,Hepatic Stellate Cell,Stellate Cell, Hepatic,Stellate Cells, Hepatic
D058750 Epithelial-Mesenchymal Transition Phenotypic changes of EPITHELIAL CELLS to MESENCHYME type, which increase cell mobility critical in many developmental processes such as NEURAL TUBE development. NEOPLASM METASTASIS and DISEASE PROGRESSION may also induce this transition. Epithelial-Mesenchymal Transformation,Epithelial Mesenchymal Transformation,Epithelial Mesenchymal Transition,Transformation, Epithelial-Mesenchymal,Transition, Epithelial-Mesenchymal
D062085 RNA, Long Noncoding A class of untranslated RNA molecules that are typically greater than 200 nucleotides in length and do not code for proteins. Members of this class have been found to play roles in transcriptional regulation, post-transcriptional processing, CHROMATIN REMODELING, and in the epigenetic control of chromatin. LincRNA,RNA, Long Untranslated,LINC RNA,LincRNAs,Long Intergenic Non-Protein Coding RNA,Long Non-Coding RNA,Long Non-Protein-Coding RNA,Long Noncoding RNA,Long ncRNA,Long ncRNAs,RNA, Long Non-Translated,lncRNA,Long Intergenic Non Protein Coding RNA,Long Non Coding RNA,Long Non Protein Coding RNA,Long Non-Translated RNA,Long Untranslated RNA,Non-Coding RNA, Long,Non-Protein-Coding RNA, Long,Non-Translated RNA, Long,Noncoding RNA, Long,RNA, Long Non Translated,RNA, Long Non-Coding,RNA, Long Non-Protein-Coding,Untranslated RNA, Long,ncRNA, Long,ncRNAs, Long
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Yating Zhan, and Qiqi Tao, and Qishan Meng, and Rongrong Zhang, and Lifan Lin, and Xinmiao Li, and Lei Zheng, and Jianjian Zheng
June 2023, Cell cycle (Georgetown, Tex.),
Yating Zhan, and Qiqi Tao, and Qishan Meng, and Rongrong Zhang, and Lifan Lin, and Xinmiao Li, and Lei Zheng, and Jianjian Zheng
January 2020, Biochemical and biophysical research communications,
Yating Zhan, and Qiqi Tao, and Qishan Meng, and Rongrong Zhang, and Lifan Lin, and Xinmiao Li, and Lei Zheng, and Jianjian Zheng
March 2024, Communications biology,
Yating Zhan, and Qiqi Tao, and Qishan Meng, and Rongrong Zhang, and Lifan Lin, and Xinmiao Li, and Lei Zheng, and Jianjian Zheng
June 2023, World journal of gastroenterology,
Yating Zhan, and Qiqi Tao, and Qishan Meng, and Rongrong Zhang, and Lifan Lin, and Xinmiao Li, and Lei Zheng, and Jianjian Zheng
January 2018, Cancer biomarkers : section A of Disease markers,
Yating Zhan, and Qiqi Tao, and Qishan Meng, and Rongrong Zhang, and Lifan Lin, and Xinmiao Li, and Lei Zheng, and Jianjian Zheng
April 2017, International journal of oncology,
Yating Zhan, and Qiqi Tao, and Qishan Meng, and Rongrong Zhang, and Lifan Lin, and Xinmiao Li, and Lei Zheng, and Jianjian Zheng
July 2019, Oncology letters,
Yating Zhan, and Qiqi Tao, and Qishan Meng, and Rongrong Zhang, and Lifan Lin, and Xinmiao Li, and Lei Zheng, and Jianjian Zheng
September 2018, Biochemical and biophysical research communications,
Yating Zhan, and Qiqi Tao, and Qishan Meng, and Rongrong Zhang, and Lifan Lin, and Xinmiao Li, and Lei Zheng, and Jianjian Zheng
February 2017, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
Yating Zhan, and Qiqi Tao, and Qishan Meng, and Rongrong Zhang, and Lifan Lin, and Xinmiao Li, and Lei Zheng, and Jianjian Zheng
July 2010, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Copied contents to your clipboard!